Citi Discount Zert 0QF 26.06.2024/ DE000KH38WB1 /

5/24/2024 9:50:12 PM	Chg.-0.31	Bid10:00:04 PM	Ask10:00:04 PM	Underlying	Strike price	Expiration date	Option type
91.63EUR	-0.34%	- Bid Size: -	- Ask Size: -	MODERNA INC. DL-...	- -	6/26/2024	Call

GlobeNewswire 5/22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire 5/22 Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...

TeleTrader 5/20 Dow slumps 195 points at closing bell after corporate news

GlobeNewswire 5/16 CytomX Therapeutics Announces New Employment Inducement Grants

TeleTrader 5/13 Wall Street closes mixed ahead of key inflation data

GlobeNewswire 5/12 TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...

GlobeNewswire 5/8 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 5/8 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...

TeleTrader 5/2 US surges at close as traders weigh Fed remarks

TeleTrader 5/2 Moderna surges 9% as Q1 revenue beat expectations

GlobeNewswire 5/2 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update

TeleTrader 5/2 Moderna sees $167M in Q1 revenue, beats forecasts

TeleTrader 5/2 US higher premarket after Fed's decision

GlobeNewswire 5/1 Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems

GlobeNewswire 5/1 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...

TeleTrader 4/24 Moderna, OpenAI partner on mRNA medicine advancement

TeleTrader 4/9 US markets close mostly higher ahead of inflation report

GlobeNewswire 4/4 Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...

TeleTrader 3/28 US closes mixed amid data

TeleTrader 3/26 Wall Street closes lower after economic data

GlobeNewswire 3/21 Immatics Announces Full Year 2023 Financial Results and Corporate Update

GlobeNewswire 3/11 CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

GlobeNewswire 3/4 CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

GlobeNewswire 2/29 Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update

GlobeNewswire 2/27 CytomX Therapeutics to Present at Upcoming March Investor Conferences